The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHIEVE LIFE SCIENCES INC | COM | 004468500 | 1,016,657 | 216,310 | SH | SOLE | 216,310 | 0 | 0 | ||
ADMA BIOLOGICS INC | COM | 000899104 | 16,881,800 | 1,510,000 | SH | SOLE | 1,510,000 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM NEW | 016259202 | 11,954,000 | 2,150,000 | SH | SOLE | 2,150,000 | 0 | 0 | ||
ALLURION TECHNOLOGIES INC | COM SHS | 02008G102 | 967,512 | 969,840 | SH | SOLE | 969,840 | 0 | 0 | ||
ANNOVIS BIO INC | COM | 03615A108 | 894,528 | 155,300 | SH | Put | SOLE | 155,300 | 0 | 0 | |
APPLIED DNA SCIENCES INC | COM NEW | 03815U409 | 35,184 | 86,152 | SH | SOLE | 86,152 | 0 | 0 | ||
APREA THERAPEUTICS INC | COM NEW | 03836J201 | 558,392 | 137,197 | SH | SOLE | 137,197 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 9,890,920 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 6,819,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | COM SHS | G29687103 | 8,576,600 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 4,025,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BIOVIE INC | CL A NEW | 09074F207 | 793,928 | 1,982,341 | SH | SOLE | 1,982,341 | 0 | 0 | ||
BITCOIN DEPOT INC | *W EXP 06/30/202 | 09174P113 | 2,365 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BOUNDLESS BIO INC | COM | 10170A100 | 321,787 | 83,149 | SH | SOLE | 83,149 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 7,745,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 3,750 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CEMTREX INC | COM NEW | 15130G709 | 74,791 | 339,961 | SH | SOLE | 339,961 | 0 | 0 | ||
CINGULATE INC | *W EXP 12/10/202 | 17248W113 | 2,916 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 1,417 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | ||
CONDUIT PHARMACEUTICALS INC | *W EXP 09/22/202 | 20678X114 | 1,550 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 721,802 | 360,001 | SH | SOLE | 360,001 | 0 | 0 | ||
CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | 7,560,677 | 429,340 | SH | SOLE | 429,340 | 0 | 0 | ||
CYBIN INC | COM | 23256X100 | 3,781,395 | 13,953,488 | SH | SOLE | 13,953,488 | 0 | 0 | ||
EVOKE PHARMA INC | COM NEW | 30049G203 | 366,301 | 692,440 | SH | SOLE | 692,440 | 0 | 0 | ||
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 569,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 12,730,000 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
INTELLIGENT BIO SOLUTIONS IN | COM | 36151G600 | 161,100 | 83,906 | SH | SOLE | 83,906 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 13,218,570 | 193,000 | SH | SOLE | 193,000 | 0 | 0 | ||
JEFFS BRANDS LTD | *W EXP 99/99/999 | M61472110 | 2,198 | 68,681 | SH | SOLE | 68,681 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 642,024 | 740,000 | SH | SOLE | 740,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 5,024,250 | 693,000 | SH | SOLE | 693,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,421,000 | 196,000 | SH | Call | SOLE | 0 | 0 | 0 | |
LEXICON PHARMACEUTICALS INC | COM NEW | 528872302 | 204,936 | 121,986 | SH | SOLE | 121,986 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 1,336,326 | 1,012,368 | SH | SOLE | 1,012,368 | 0 | 0 | ||
MOBIX LABS INC | *W EXP 99/99/999 | 60743G118 | 26,820 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 5,056,550 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
NEXALIN TECHNOLOGY INC | *W EXP 99/99/999 | 65345B110 | 35,700 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 98,325 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
NLS PHARMACEUTICS LTD | *W EXP 02/02/202 | H57830111 | 6,900 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ONFOLIO HOLDINGS INC | *W EXP 01/02/202 | 68277K124 | 49,760 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 2,863,350 | 405,000 | SH | SOLE | 405,000 | 0 | 0 | ||
OUTLOOK THERAPEUTICS INC | COM | 69012T305 | 3,703,173 | 501,785 | SH | SOLE | 501,785 | 0 | 0 | ||
PERFECT MOMENT LTD | COM SHS | 713715100 | 135,095 | 62,835 | SH | SOLE | 62,835 | 0 | 0 | ||
PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 1,908,757 | 191,450 | SH | SOLE | 191,450 | 0 | 0 | ||
QUOIN PHARMACEUTICALS LTD | SPONSORED ADS | 74907L300 | 59,814 | 103,127 | SH | SOLE | 103,127 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 610,000 | 200,000 | SH | Call | SOLE | 0 | 0 | 0 | |
REZOLUTE INC | COM NEW | 76200L309 | 7,310,000 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 44,406 | 731,561 | SH | SOLE | 731,561 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 12,940,200 | 81,900 | SH | SOLE | 81,900 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 6,347,250 | 1,575,000 | SH | SOLE | 1,575,000 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 80,600 | 20,000 | SH | Call | SOLE | 0 | 0 | 0 | |
SELINA HOSPITALITY PLC | *W EXP 10/27/202 | G8059B119 | 1,101 | 101,439 | SH | SOLE | 101,439 | 0 | 0 | ||
SKYE BIOSCIENCE INC | COM NEW | 83086J200 | 10,814,245 | 1,350,093 | SH | SOLE | 1,350,093 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 8,686,687 | 212,909 | SH | SOLE | 212,909 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 419,941 | 811,167 | SH | SOLE | 811,167 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 1,365 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | ||
TC BIOPHARM HOLDINGS PLC | *W EXP 02/10/202 | 87807D111 | 235 | 18,823 | SH | SOLE | 18,823 | 0 | 0 | ||
THE REALREAL INC | COM | 88339P101 | 3,988,259 | 1,250,238 | SH | SOLE | 1,250,238 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 2,877,000 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 25,832,520 | 714,000 | SH | SOLE | 714,000 | 0 | 0 | ||
VERU INC | COM | 92536C103 | 1,915,381 | 2,276,692 | SH | SOLE | 2,276,692 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 6,467,220 | 122,000 | SH | SOLE | 122,000 | 0 | 0 | ||
VSEE HEALTH INC | *W EXP 99/99/999 | 92919Y110 | 32,460 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
WEARABLE DEVICES LTD | *W EXP 09/14/202 | M97838110 | 70,015 | 1,411,600 | SH | SOLE | 1,411,600 | 0 | 0 | ||
WESTERN ACQSTN VENTURES CORP | *W EXP 99/99/999 | 95758L115 | 3,660 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 14,059,794 | 360,600 | SH | SOLE | 360,600 | 0 | 0 | ||
XTANT MED HLDGS INC | COM NEW | 98420P308 | 4,671,711 | 7,415,413 | SH | SOLE | 7,415,413 | 0 | 0 | ||
ZEVRA THERAPEUTICS INC | COM NEW | 488445206 | 5,695,838 | 1,162,416 | SH | SOLE | 1,162,416 | 0 | 0 |